Stocks and Investing
Stocks and Investing
Tue, November 7, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Bruce Jackson Reiterated (BLTE) at Strong Buy and Held Target at $57 on, Nov 7th, 2023
Bruce Jackson of Benchmark, Reiterated "Belite Bio, Inc" (BLTE) at Strong Buy and Held Target at $57 on, Nov 7th, 2023.
Bruce has made no other calls on BLTE in the last 4 months.
There are 3 other peers that have a rating on BLTE. Out of the 3 peers that are also analyzing BLTE, 0 agree with Bruce's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Bruce
- Yi Chen of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $59 on, Monday, November 6th, 2023
- Jennifer Kim of "Cantor Fitzgerald" Initiated at Buy and Held Target at $43 on, Friday, July 28th, 2023
- Marc Goodman of "SVB Leerink" Initiated at Buy and Held Target at $25 on, Wednesday, July 26th, 2023
Contributing Sources